Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis
Shin Ishikane, Fumi Takahashi‐Yanaga
Biochemical Pharmacology (2018) Vol. 151, pp. 96-103
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Epidemiology and Prevention of Renal Cell Carcinoma
Tomoyuki Makino, Suguru Kadomoto, Kouji Izumi, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4059-4059
Open Access | Times Cited: 76
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies
Valentina Schiavoni, Roberto Campagna, Valentina Pozzi, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3207-3207
Open Access | Times Cited: 32
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Bahareh Hassani, Zeinab Attar, Negar Firouzabadi
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 23
SARS-CoV-2 and cancer: Are they really partners in crime?
Peter A. van Dam, Manon Huizing, Gino Mestach, et al.
Cancer Treatment Reviews (2020) Vol. 89, pp. 102068-102068
Open Access | Times Cited: 68
The Effect of Local Renin Angiotensin System in the Common Types of Cancer
Moudhi Almutlaq, Abir Alamro, Hassan S. Alamri, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 43
Metabolic syndrome and thyroid Cancer: risk, prognosis, and mechanism
Lingrui Li, Jun‐Long Song, Hanqing Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
Imogen Roth, Agadha Wickremesekera, Susrutha K. Wickremesekera, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 43
Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment
Ethan J. Kilmister, Sabrina P. Koh, Freya R. Weth, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2988-2988
Open Access | Times Cited: 25
GPCR Modulation in Breast Cancer
Rosamaria Lappano, Yves Jacquot, Marcello Maggiolini
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3840-3840
Open Access | Times Cited: 45
Angiotensin II and Angiotensin Receptors 1 and 2—Multifunctional System in Cells Biology, What Do We Know?
Maksymilian Ziaja, Kinga Anna Urbanek, Karolina Kowalska, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 381-381
Open Access | Times Cited: 32
Leveling Up the Controversial Role of Neutrophils in Cancer: When the Complexity Becomes Entangled
Ronit Vogt Sionov
Cells (2021) Vol. 10, Iss. 9, pp. 2486-2486
Open Access | Times Cited: 28
Angiotensin II Promotes Osteocyte RANKL Expression via AT1R Activation
Jiayi Ren, Aseel Marahleh, Jinghan Ma, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 426-426
Open Access
A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes
Philip Dusart, Björn M. Hallström, Thomas Renné, et al.
Cell Reports (2019) Vol. 29, Iss. 6, pp. 1690-1706.e4
Open Access | Times Cited: 30
Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma
Yu‐Tsai Lin, Hung‐Chen Wang, Ming‐Hsien Tsai, et al.
Cancer (2021) Vol. 127, Iss. 10, pp. 1606-1619
Open Access | Times Cited: 24
Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?
M. Barone
World Journal of Gastroenterology (2024) Vol. 30, Iss. 18, pp. 2391-2396
Open Access | Times Cited: 3
Involvement of ACE2/Ang-(1-7)/MAS1 Axis in the Regulation of Ovarian Function in Mammals
Kamila Domińska
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4572-4572
Open Access | Times Cited: 27
Stress and cancer. Part II: Therapeutic implications for oncology
Boris Mravec, Miroslav Tibenský, Ľubica Horváthová
Journal of Neuroimmunology (2020) Vol. 346, pp. 577312-577312
Closed Access | Times Cited: 25
Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
Paolo Gelosa, Laura Castiglioni, Marina Camera, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113895-113895
Open Access | Times Cited: 24
Risk of lung cancer and renin–angiotensin blockade: a concise review
Tobias Rachow, Helmut Schiffl, Susanne Lang
Journal of Cancer Research and Clinical Oncology (2020) Vol. 147, Iss. 1, pp. 195-204
Open Access | Times Cited: 21
Modulation of the Tumor Stroma and Associated Novel Nanoparticle Strategies to Enhance Tumor Targeting
H. Haze, Cornelis F.M. Sier, Alexander L. Vahrmeijer, et al.
Surgeries (2024) Vol. 5, Iss. 1, pp. 49-62
Open Access | Times Cited: 2
20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1
Yuchen Wang, Huali Xu, Wenwen Fu, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 21
The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, et al.
Life Sciences (2021) Vol. 270, pp. 119118-119118
Closed Access | Times Cited: 17
The role of the renin-angiotensin system inhibitors in malignancy: a review.
Ju Yang, Xi Yang, Ling Gao, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 3, pp. 884-897
Closed Access | Times Cited: 17
RAAS: A Convergent Player in Ischemic Heart Failure and Cancer
Texali-Candelaria Garcia-Garduño, Jorge Ramón Padilla‐Gutiérrez, Diego Cambrón-Mora, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7106-7106
Open Access | Times Cited: 14
Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma
Long-Hai Feng, Hui–Chuan Sun, Xiao‐Dong Zhu, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 3, pp. 207-207
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top